“Threshold-crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
“Threshold-crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 100, Issue 6, Pages 699-712
Publisher
Wiley
Online
2016-09-21
DOI
10.1002/cpt.515
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inverse probability weighting
- (2016) Mohammad Ali Mansournia et al. BMJ-British Medical Journal
- Inverse probability weighting
- (2016) Mohammad Ali Mansournia et al. BMJ-British Medical Journal
- Early market access of cancer drugs in the EU
- (2015) J. Martinalbo et al. ANNALS OF ONCOLOGY
- The role of nonrandomized trials in the evaluation of oncology drugs
- (2015) R Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies
- (2015) Carlijn CM Welten et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 2014 FDA drug approvals
- (2015) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Prospects for the development of epigenetic drugs for CNS conditions
- (2015) Moshe Szyf NATURE REVIEWS DRUG DISCOVERY
- Targeted Anti-Anticoagulants
- (2015) Kenneth A. Bauer NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of Mitoxantrone Plus Prednisone Versus Prednisone Alone in Metastatic Castrate-Resistant Prostate Cancer After Docetaxel Failure
- (2015) A. K. Green et al. ONCOLOGIST
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- (2015) Peter Bauer et al. STATISTICS IN MEDICINE
- Effectiveness, safety and costs of orphan drugs: an evidence-based review
- (2015) Igho J Onakpoya et al. BMJ Open
- Personalising results from large trials
- (2015) R. Perera et al. BMJ-British Medical Journal
- Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
- (2015) Ben S. Cooper et al. PLOS MEDICINE
- Personalising results from large trials
- (2015) R. Perera et al. BMJ-British Medical Journal
- Choosing Appropriate Estimands in Clinical Trials
- (2015) Ann-Kristin Leuchs et al. Therapeutic Innovation & Regulatory Science
- Sharing clinical trial data on patient level: Opportunities and challenges
- (2014) Franz Koenig et al. BIOMETRICAL JOURNAL
- Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012
- (2014) Nicholas S. Downing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- European perspective for effective cancer drug development
- (2014) Denis Lacombe et al. Nature Reviews Clinical Oncology
- Data Sharing, Year 1 — Access to Data from Industry-Sponsored Clinical Trials
- (2014) Brian L. Strom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
- (2014) Amelie Elsäßer et al. Trials
- Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
- (2013) Jelena Savović et al. ANNALS OF INTERNAL MEDICINE
- Adaptive adjustment of the randomization ratio using historical control data
- (2013) Brian P Hobbs et al. Clinical Trials
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Using historical control information for the design and analysis of clinical trials with overdispersed count data
- (2013) Sandro Gsteiger et al. STATISTICS IN MEDICINE
- Disease risk score as a confounder summary method: systematic review and recommendations
- (2012) Mina Tadrous et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers
- (2011) Iain Chalmers JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
- (2011) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- The inclusion of historical control data may reduce the power of a confirmatory study
- (2011) Robert L. Cuffe STATISTICS IN MEDICINE
- Summarizing historical information on controls in clinical trials
- (2010) Beat Neuenschwander et al. Clinical Trials
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
- (2008) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Bias modelling in evidence synthesis
- (2008) Rebecca M. Turner et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started